3
Views
10
CrossRef citations to date
0
Altmetric
Research Article

A double-blind, multi-centre trial comparing the efficacy and side-effects of mianserin and clomipramine in depressed in-patients and out-patients

, , , , , , , & show all
Pages 115-127 | Accepted 19 Sep 1979, Published online: 21 Aug 2008

Reference

  • Beck A. T., Ward C. H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961; 4: 561–5711. Beck A. T., Ward C. H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961; 4: 561–571
  • Bigger J. T., Kantor S. J., Glassman A. H., Perel U. M. Cardiovascular effects of tricyclic antidepressant drugs. Psychopharmacology. A Generation of Progress, M. A. Lipton, A. Di, K. F. Mascio Killam. Raven Press, New York 1978; 1033–10462. Bigger J. T., Kantor S. J., Glassman A. H., Perel U. M. Cardiovascular effects of tricyclic antidepressant drugs. Psychopharmacology. A Generation of Progress, M. A. Lipton, A. Di, K. F. Mascio Killam. Raven Press, New York 1978; 1033–1046
  • Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 1978; 16: 273–3013. Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 1978; 16: 273–301
  • Drykoningen G. J., Pinder R. M., de Ridder J. J. Review of mianserin overdose cases. Progress in the Pharmacotherapy of Depression: Mianserin HCl, G. Drykoningen, W. L. Linford, L. Rees Ruiz. Ogara. ICS Excerpta Medica, Amsterdam 1979; 74–78; 4624. Drykoningen G. J., Pinder R. M., de Ridder J. J. Review of mianserin overdose cases. Progress in the Pharmacotherapy of Depression: Mianserin HCl, G. Drykoningen, W. L. Linford, L. Rees Ruiz. Ogara. ICS Excerpta Medica, Amsterdam 1979; 74–78; 462
  • Editorial., Cardiac effects of antidepressive drugs. Drug Ther. Bull. 1979; 17: 13–145. Editorial., Cardiac effects of antidepressive drugs. Drug Ther. Bull. 1979; 17: 13–14
  • Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 56–656. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 56–65
  • Jefferson I. W. A review of the cardiovascular effects and toxicity of tricyclic antidepressants. Psychosom. Med. 1975; 37: 160–1797. Jefferson I. W. A review of the cardiovascular effects and toxicity of tricyclic antidepressants. Psychosom. Med. 1975; 37: 160–179
  • Kopera H., Schenk H. Antidepressiva und Kardiotoxizitat. Dtsch. Med. Wochenschr. 1978; 103: 1373–13768. Kopera H., Schenk H. Antidepressiva und Kardiotoxizitat. Dtsch. Med. Wochenschr. 1978; 103: 1373–1376
  • Peet M., Turner P. Proceedings of a symposium on mianserin. Br. J. Clin. Pharmacol. 1978; 5: 5S–99S, Suppl. 19. Peet M., Turner P. Proceedings of a symposium on mianserin. Br. J. Clin. Pharmacol. 1978; 5: 5S–99S, Suppl. 1
  • Schatzberg A. F., Cole J. O. Benzodiazepines in depressive disorders. Arch. Gen. Psychiatry 1978; 35: 1359–136510. Schatzberg A. F., Cole J. O. Benzodiazepines in depressive disorders. Arch. Gen. Psychiatry 1978; 35: 1359–1365
  • Spiker D. G. The toxicity of tricyclic antidepressants. Commun. Psychopharmacol. 1978; 2: 419–42711. Spiker D. G. The toxicity of tricyclic antidepressants. Commun. Psychopharmacol. 1978; 2: 419–427
  • Yates F. The analysis of contingency tables with groupings based upon quantitative characters. Biometrika 1948; 25: 176–18112. Yates F. The analysis of contingency tables with groupings based upon quantitative characters. Biometrika 1948; 25: 176–181
  • Montgomery S. A., McAuley R., Montgomery D. B. Relationship between mianserin plasma levels and antidepressant effect in a double-blind trial comparing a single nighttime and divided daily dose regimens. Br. J. Clin. Pharmacol. 1978; 5: 71S, Suppl. 113. Montgomery S. A., McAuley R., Montgomery D. B. Relationship between mianserin plasma levels and antidepressant effect in a double-blind trial comparing a single nighttime and divided daily dose regimens. Br. J. Clin. Pharmacol. 1978; 5: 71S, Suppl. 1
  • Montgomery S. A., McAuley R., Montgomery D. B., Braithwaite R. A., Dawling S. Dosage adjustment from simple nortriptyline spot level predictor tests in depressed patients. Clin. Pharmacokinet. 1979; 4: 12914. Montgomery S. A., McAuley R., Montgomery D. B., Braithwaite R. A., Dawling S. Dosage adjustment from simple nortriptyline spot level predictor tests in depressed patients. Clin. Pharmacokinet. 1979; 4: 129
  • Montgomery S. A., McAuley R., Rani S. J., Montgomery D. B., Braithwaite R. A., Dawling S. Amitriptyline plasma concentrations and clinical response. Br. Med. J. 1979; 1: 23015. Montgomery S. A., McAuley R., Rani S. J., Montgomery D. B., Braithwaite R. A., Dawling S. Amitriptyline plasma concentrations and clinical response. Br. Med. J. 1979; 1: 230
  • Porter A. M. W. Drug defaulting in general practice. Br. Med. J. 1969; 1: 21816. Porter A. M. W. Drug defaulting in general practice. Br. Med. J. 1969; 1: 218
  • Russell G. F. M., Niaz U., Wakeling A., Slade P. D. Comparative double-blind trial of mianserin hydrochloride (Organon GB 94) and diazepam in patients with depressive illness. Br. J. Clin. Pharmacol. 1978; 5: 57S, Suppl. 117. Russell G. F. M., Niaz U., Wakeling A., Slade P. D. Comparative double-blind trial of mianserin hydrochloride (Organon GB 94) and diazepam in patients with depressive illness. Br. J. Clin. Pharmacol. 1978; 5: 57S, Suppl. 1
  • World Health Organization. “International Classification of Diseases” 8th revision. W.H.O., Geneva 196918. World Health Organization. “International Classification of Diseases” 8th revision. W.H.O., Geneva 1969
  • World Health Organization. “International Classification of Diseases” 9th revision. W.H.O., Geneva 197819. World Health Organization. “International Classification of Diseases” 9th revision. W.H.O., Geneva 1978

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.